Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1084/jem.20172044 http://scihub22266oqcxt.onion/10.1084/jem.20172044 C5748866!5748866!29263217     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Exp+Med 2018 ; 215 (1): 9-11 Nephropedia Template TP {{tp|p=29263217|t=2018. Resolving the dark side of therapy-driven cancer cell death |pdf=|usr=}}{{29263217}} gab.com Text Resolving the dark side of therapy-driven cancer cell death JO: J Exp Med http://www.kidney.de/pget.php?&tw=1&pmid=29263217 #FOAvip In this issue of JEM, Sulciner et al. (https://doi.org/10.1084/jem.20170681) provide evidence that therapy-induced cancer cell death can, paradoxically, stimulate and accelerate the growth of surviving malignant cells by fueling tumor-promoting inflammation. Resolvins, a class of lipid mediators, counteract this effect, representing an attractive target for therapeutic intervention. Twit Text FOAVip Resolving the dark side of therapy-driven cancer cell death ????J Exp Med http://www.kidney.de/pget.php?&tw=1&pmid=29263217 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29263217 #FOAvip English Wikipedia <ref>{{Cite pmid|29263217}}</ref> Resolving the dark side of therapy-driven cancer cell death #MMPMID29263217 Bonavita E; Pelly VS; Zelenay S J Exp Med 2018[Jan]; 215 (1): 9-11 PMID29263217show ga In this issue of JEM, Sulciner et al. (https://doi.org/10.1084/jem.20170681) provide evidence that therapy-induced cancer cell death can, paradoxically, stimulate and accelerate the growth of surviving malignant cells by fueling tumor-promoting inflammation. Resolvins, a class of lipid mediators, counteract this effect, representing an attractive target for therapeutic intervention. äResolving the dark side of therapy-driven cancer cell death (epmc).pdf DeepDyve Pubget Overpricing